Latest Breaking News On - Astra merck - Page 3 : comparemela.com
DTx leader Sidekick announces key C-level hires in move to accelerate U S market growth
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Austin Inno - Austin tech and startup moves: Indeed adds to senior leadership team; Invicti gets new CEO
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Posted on 461
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board. The Merck board of directors has unanimously elected Robert M. Davis, Merck’s current executive vice president, global services and chief financial officer, as chief executive officer, as well as a member of the board, effective July 1, 2021. Mr. Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions Human Health, Animal Health, Manufacturing, and Merck Research Laboratories will begin reporting to him.
Merck’s CEO Kenneth Frazier to retire after ten years in the role
Frazier is handing the reins over to current Merck CFO Robert Davis
Merck & Co’s chief executive officer (CEO) Kenneth Frazier (pictured left) is set to retire, ten years after taking the helm at the pharma giant.
Frazier joined Merck in 1992 as vice president, general counsel and secretary of the Astra Merck group.
Since then, he has advanced in the company, holding increasingly senior roles across the organisation, ultimately being appointed president of Merck in May 2010.
In January 2011, he took on the role of CEO and also became chairman of the board in December of that year.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman
February 4, 2021 GMT
KENILWORTH, N.J. (BUSINESS WIRE) Feb 4, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board. The Merck board of directors has unanimously elected Robert M. Davis, Merck’s current executive vice president, global services and chief financial officer, as chief executive officer, as well as a member of the board, effective July 1, 2021. Mr. Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions Huma
vimarsana © 2020. All Rights Reserved.